Se connecter

Bibliographies thématiques / Tumor Residual

Sommaire

Articles de revues
Thèses
Livres
Chapitres de livres
Actes de conférences
Rapports d'organisations

Littérature scientifique sur le sujet « Tumor Residual »

Auteur : Grafiati

Publié le 9 mars 2023

Mis à jour le 31 juillet 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Tumor Residual ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Articles de revues sur le sujet "Tumor Residual"

1

Kasbekar, Anand, Guleed Adan, Alaina Beacall, Ahmed Youssef, Catherine Gilkes, and Tristram Lesser. "Growth Patterns of Residual Tumor in Preoperatively Growing Vestibular Schwannomas." Journal of Neurological Surgery Part B: Skull Base 79, no. 04 (2017): 319–24. http://dx.doi.org/10.1055/s-0037-1607421.

Texte intégral

Résumé :

Objectives To analyze growth of residual vestibular schwannoma (VS) following incomplete tumor resection and determine the influence of residual location and size. Design Retrospective case note and scan review. Setting Tertiary skull base unit. Participants Patients with residual tumor following primary surgery for medium and large unilateral growing vestibular schwanomas between 2006 and 2009. Main Outcome Measures Location of residual VS and post-operative growth, comparing those with more (>5%) or less than 5% of tumor residual (<5%). Results Fifty-two patients had visible residual t

Styles APA, Harvard, Vancouver, ISO, etc.

2

Panni, Roheena Z., Ivan Gonzalez, Christopher P. Hartley, et al. "Residual Tumor Index." American Journal of Surgical Pathology 42, no. 11 (2018): 1480–87. http://dx.doi.org/10.1097/pas.0000000000001144.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

3

Wittekind, Christian, and Paul Hermanek. "Residual Tumor Classification." Advances in Anatomic Pathology 2, no. 4 (1995): 277–79. http://dx.doi.org/10.1097/00125480-199507000-00055.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

4

Kishida, Takeshi. "Postchemotherapy residual tumor." Annals of Oncology 28 (October 2017): ix52. http://dx.doi.org/10.1093/annonc/mdx627.001.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

5

Xu, Xiaohong, Liangping Luo, Jiexin Chen, et al. "Acoustic Radiation Force Impulse Elastography for Efficacy Evaluation after Hepatocellular Carcinoma Radiofrequency Ablation: A Comparative Study with Contrast-Enhanced Ultrasound." BioMed Research International 2014 (2014): 1–7. http://dx.doi.org/10.1155/2014/901642.

Texte intégral

Résumé :

Aim. To explore acoustic radiation force impulse (ARFI) elastography in assessing residual tumors of hepatocellular carcinoma (HCC) after radiofrequency ablation (RFA).Materials and Methods. There were 83 HCC lesions among 72 patients. All patients were examined with ARFI, contrast enhanced ultrasound (CEUS), and CT or MRI. Tumor brightness on virtual touch tissue imaging (VTI) and shear wave velocity (SWV) were assessed before and approximately one month after RFA.Results. There were 14 residual tumors after RFA. VTI showed that all the tumors were darker after RFA. VTI was not able to distin

Styles APA, Harvard, Vancouver, ISO, etc.

6

Yi, Huiming, Baohuan Cai, Xi Ai, Kaiyan Li, Pengfei Song, and Wei Zhang. "Early Identification of Residual Tumors following Microwave Ablation Using Contrast-Enhanced Ultrasonography in a Rabbit VX2 Liver Cancer Model." BioMed Research International 2020 (September 27, 2020): 1–9. http://dx.doi.org/10.1155/2020/2462058.

Texte intégral

Résumé :

Objective. It is difficult to evaluate the ablation effect immediately after thermal ablation of liver cancer by clinical imaging methods, due to the immediate formation of an annular inflammatory reaction band (IRB). This study is aimed at exploring the early identification indicators of the IRB and residual tumor postmicrowave ablation (MVA) using contrast-enhanced ultrasonography (CEUS). Methods. MVA was used to inactivate part of the tumor nodules in rabbit VX2 liver cancer models, leading to the coexistence of the IRB with residual tumors. Quantitative analysis of the perfusion parameters

Styles APA, Harvard, Vancouver, ISO, etc.

7

Widhalm, Georg, Stefan Wolfsberger, Matthias Preusser, et al. "Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression." Journal of Neurosurgery 111, no. 3 (2009): 563–71. http://dx.doi.org/10.3171/2008.4.17517.

Texte intégral

Résumé :

Object In residual nonfunctioning pituitary adenomas, reliable prognostic parameters indicating probability of tumor progression are needed. The Ki 67 expression/MIB-1 labeling index (LI) is considered to be a promising candidate factor. The aim in the present study was to analyze the clinical usefulness of MIB-1 LI for prognosis of tumor progression. Methods The authors studied a cohort of 92 patients with nonfunctioning pituitary adenomas. Based on sequential postoperative MR images, patients were classified as tumor free (51 patients) or as harboring residual tumor (41 individuals). The res

Styles APA, Harvard, Vancouver, ISO, etc.

8

Wang, Zhiming, Hala S. Hassanain, Erin He, et al. "Abstract P3-02-28: A combination approach to target residual tumors via ferroptosis induction." Clinical Cancer Research 31, no. 12_Supplement (2025): P3–02–28—P3–02–28. https://doi.org/10.1158/1557-3265.sabcs24-p3-02-28.

Texte intégral

Résumé :

Abstract Background: Selection pressure from chemotherapy can result in small populations of resistant cells, even in tumors with apparent clinical response. These residual tumor cells can tolerate cytotoxic treatments, persist in a reversible, semi-dormant, diapause-like state, and ultimately drive tumor recurrence. Pharmacologically targeting these residual tumor cells has the potential to prevent or significantly delay tumor relapse, but it remains a clinical challenge. Methods and Results: We report ferroptosis induction as a targeting strategy to eradicate residual tumor cells following c

Styles APA, Harvard, Vancouver, ISO, etc.

9

De Santis, Maria, Alexander Becherer, Carsten Bokemeyer, et al. "2-18fluoro-deoxy-D-glucose Positron Emission Tomography Is a Reliable Predictor for Viable Tumor in Postchemotherapy Seminoma: An Update of the Prospective Multicentric SEMPET Trial." Journal of Clinical Oncology 22, no. 6 (2004): 1034–39. http://dx.doi.org/10.1200/jco.2004.07.188.

Texte intégral

Résumé :

Purpose To define the clinical value of 2-18fluoro-deoxy-D-glucose positron emission tomography (FDG PET) as a predictor for viable residual tumor in postchemotherapy seminoma residuals in a prospective multicentric trial. Patients and Methods FDG PET studies in patients with metastatic pure seminoma who had radiographically defined postchemotherapy residual masses were correlated with either the histology of the resected lesion or the clinical outcome documented by computer tomography (CT), tumor markers, and/or physical examination during follow-up. The size of the residual lesions on CT, ei

Styles APA, Harvard, Vancouver, ISO, etc.

10

Lusch, A., and P. Albers. "Residual tumor resection (RTR)." World Journal of Urology 35, no. 8 (2016): 1185–90. http://dx.doi.org/10.1007/s00345-016-1984-2.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Plus de sources

Thèses sur le sujet "Tumor Residual"

1

Takeda, Kazuna. "MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy." Kyoto University, 2012. http://hdl.handle.net/2433/157449.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

2

Oliveira, Marcelo de Lima. "Ultrassonografia durante cirurgia para metástase cerebral: influência no índice de Karnofsky e volume do tumor residual." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/5/5138/tde-09082016-151729/.

Texte intégral

Résumé :

Introdução: Os principais objetivos do tratamento das metástases cerebrais (MC) são no auxílio do controle da doença no encéfalo e a melhora da qualidade de vida dos pacientes. A cirurgia convencional tem um importante papel no tratamento das MCs e os métodos de monitoração intraoperatória podem auxiliar na obtenção de resultados cirúrgicos melhores. Objetivos: Avaliar a influência da ultrassonografia encefálica durante cirurgia para ressecção de MC no índice de Karnofsky e no grau de ressecção do tumor. Métodos: Neste estudo prospectivo controlado e não randomizado, doentes com indicação de t

Styles APA, Harvard, Vancouver, ISO, etc.

3

Costa-Gurgel, Maria Salete 1956. "Aspectos histologicos relacionados com a persistencia de tumor residual apos conização em pacientes com carcinoma microinvasivo do colo uterino." [s.n.], 1994. http://repositorio.unicamp.br/jspui/handle/REPOSIP/310012.

Texte intégral

Résumé :

Orientador: Aloisio José Bedone<br>Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas<br>Made available in DSpace on 2018-07-19T18:28:24Z (GMT). No. of bitstreams: 1 Costa-Gurgel_MariaSalete_M.pdf: 1948436 bytes, checksum: 9652cc74f1c4e8abd0a8359398a304a0 (MD5) Previous issue date: 1994<br>Resumo: O tratamento do carcinoma microinvasivo do colo uterino é bastante controverso, sendo abordado diferentemente nos diversos Serviços. A histerectomia, acompanhada ou não de procedimentos mais radicais, é realizada na quase totalidade dos casos. Mais recentement

Styles APA, Harvard, Vancouver, ISO, etc.

4

Marighetti, P. "RESIDUAL DORMANT CANCER STEM CELL FOCI ARE RESPONSIBLE FOR TUMOR RELAPSE AFTER ANGIOGENIC METRONOMIC THERAPY IN HEPATOCELLULAR CARCINOMA XENOGRAFTS." Doctoral thesis, Università degli Studi di Milano, 2012. http://hdl.handle.net/2434/169919.

Texte intégral

Résumé :

Hepatocellular carcinoma (HCC) is the fifth most common solid tumor and the third leading cause of cancer-related death. Current available chemotherapeutic options are not curative due in part to their resistance to conventional therapies. We have generated orthotopic HCC mouse models in immunodeficient NOD/SCID/IL2rγ null mice by injection of AFP- and/or luciferase-expressing HCC cell lines and primary cells from patients, where tumor growth and spread can be accurately monitored in a non-invasive way. Low dose metronomic administration of cyclophosphamide (LDM-CTX) causes in this model comp

Styles APA, Harvard, Vancouver, ISO, etc.

5

Vu-Han, Tu-Lan [Verfasser], and Reinhard [Akademischer Betreuer] Schneppenheim. "Identifying Molecular Markers for the Sensitive Detection of Residual Atypical Teratoid Rhaboid-Tumor Cells / Tu-Lan Vu-Han. Betreuer: Reinhard Schneppenheim." Hamburg : Staats- und Universitätsbibliothek Hamburg, 2016. http://d-nb.info/1082347604/34.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

6

Vu-Han, Tu-Lan Verfasser], and Reinhard [Akademischer Betreuer] [Schneppenheim. "Identifying Molecular Markers for the Sensitive Detection of Residual Atypical Teratoid Rhaboid-Tumor Cells / Tu-Lan Vu-Han. Betreuer: Reinhard Schneppenheim." Hamburg : Staats- und Universitätsbibliothek Hamburg, 2016. http://nbn-resolving.de/urn:nbn:de:gbv:18-77221.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

7

Morales, Murillo Serafín. "Cáncer de mama: utilidad pronóstica de los Perfiles de Expresión Proteica en pacientes con tumor residual viable (>1.0cm.) tras Quimioterapia neoadyuvante." Doctoral thesis, Universitat de Lleida, 2015. http://hdl.handle.net/10803/401677.

Texte intégral

Résumé :

La identificació de marcadors moleculars en el tumor residual després de quimioteràpia neoadjuvant ( QTN ) en Càncer de Mama permet una millor caracterització pronostica . S'han seleccionat un total de 256 pacients amb QTN entre 1996 i 2011 , amb tumor residual ( > 1 cm ) . S'ha realitzat una matriu matricial de teixits i estudi inmunohistoquimic de l'expressió de 29 marcadors moleculars . L'anàlisi s'ha realitzat sobre l'aparició de metàstasi i la supervivència lliure de progressió a distància . El model multivariant ( mètode stepwise ) obté una signatura molecular amb sis marcadors de mal pr

Styles APA, Harvard, Vancouver, ISO, etc.

8

PEIRETTI, MICHELE. "Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: surgical and oncological outcomes. single institution experience." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2010. http://hdl.handle.net/10281/8049.

Texte intégral

Résumé :

Objective. The objective of the present study was to determinate the impact of maximal cytoreductive surgery on progression free survival, overall survival rates and morbidity, in patients with advanced epithelial ovarian or fallopian tube cancer (stage IIIC-IV) treated in a referral cancer center. Methods. After obtaining Institutional Review Board approval, we reviewed all medical records of patients with stage IIIC–IV epithelial ovarian cancer who were managed at our institution between January 2001 and December 2008. Individual records were reviewed and the following information collected

Styles APA, Harvard, Vancouver, ISO, etc.

9

Milano, Jeronimo Buzetti. "Estudo das alterações em exames de ressonância magnética de pacientes em pós-operatório imediato de ressecção de tumores hipofisários por via transesfenoidal." Universidade de São Paulo, 2010. http://www.teses.usp.br/teses/disponiveis/5/5138/tde-22062010-125138/.

Texte intégral

Résumé :

Exames pós-operatórios de cirurgias intracranianas são difíceis de serem interpretados por apresentarem alterações morfológicas que simulam situações patológicas, como edema e tumores residuais. Com o advento de métodos de ressonância intraoperatória essa interpretação ganhou maior importância, pelo risco de re-intervenções desnecessárias. O presente estudo objetivou estabelecer as características de exames pós-operatórios normais após remoção de tumores hipofisários pela via transesfenoidal endonasal, bem como estabelecer parâmetros de remoção tumoral radical para otimização de exames intraop

Styles APA, Harvard, Vancouver, ISO, etc.

10

Rick, Oliver. "Therapieoptimierungsverfahren bei Patienten mit rezidivierten oder progredienten Keimzelltumoren." Doctoral thesis, Humboldt-Universität zu Berlin, Medizinische Fakultät - Universitätsklinikum Charité, 2004. http://dx.doi.org/10.18452/13921.

Texte intégral

Résumé :

Patienten mit metastasierten Keimzelltumoren, die einen Progress oder ein Rezidiv ihrer Erkrankung nach einer cisplatinhaltigen Vortherapie erleiden, haben eine schlechte Prognose. Unter Verwendung einer erneuten konventionellen Chemotherapie können maximal 15-30% dieser Patienten geheilt werden, so dass die Mehrzahl der Patienten an ihrer Erkrankung verstirbt. Aus diesem Grund ist die Optimierung der therapeutischen Möglichkeiten ein wesentliches Ziel. Unsere Daten zeigen, dass die Hochdosischemotherapie (HDCT) eine wesentliche therapeutische Verbesserung darstellt und mittels dieser Therapie

Styles APA, Harvard, Vancouver, ISO, etc.

Plus de sources

Livres sur le sujet "Tumor Residual"

1

Ignatiadis, Michail, Christos Sotiriou, and Klaus Pantel, eds. Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-28160-0.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

2

International Symposium on the Effects of Therapy on the Biology and Kinetics of the Surviving Tumor (1989 Vancouver, B.C.). Effects of therapy on biology and kinetics of the residual tumor: Proceedings of an International Symposium on the Effects of Therapy on the Biology and Kinetics of the Surviving Tumor, held in Vancouver, British Columbia, Canada, February 15-18, 1989. Edited by Ragaz J. 1945-. Wiley-Liss, 1990.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

3

F, Zipf Theodore, and Johnston Dennis A, eds. Leukemia and lymphoma: Detection of minimal residual disease. Humana Press, 2003.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

4

Ljung, Gunilla. Radiotherapy of prostatic adenocarcinoma: With reference to local cure characterization or residual tumour cells adverse effects. Acta Universitatis Upsaliensis, 1996.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

5

Pantel, Klaus, Michail Ignatiadis, and Christos Sotiriou. Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer. Springer, 2012.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

6

Minimal Residual Disease And Circulating Tumor Cells In Breast Cancer. Springer, 2012.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

7

Pantel, Klaus, Michail Ignatiadis, and Christos Sotiriou. Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer. Springer London, Limited, 2012.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

8

Pantel, Klaus, Michail Ignatiadis, and Christos Sotiriou. Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer. Springer Berlin / Heidelberg, 2014.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

9

Reizenstein, P., and G. Mathe. Managing Minimal Residual Malignancy in Man (Medical Oncology and Tumor Pharmacotherapy). Elsevier Science Publishing Company, 1989.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

10

Majmundar, Neil, and James K. Liu. Ventricular Tumors. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190696696.003.0009.

Texte intégral

Résumé :

Central neurocytomas are rare benign tumors that are typically located in the lateral ventricles. Because they are typically intraventricular, these tumors tend to present clinically with hydrocephalus. Currently, surgical removal with a gross-total resection is the treatment of choice. Various radiotherapy techniques, including both conventional radiotherapy and stereotactic radiosurgery, have been shown to be useful in cases of residual tumor after subtotal resection and tumor recurrence. This chapter presents a clinical case of central neurocytoma that demonstrates the typical clinical and

Styles APA, Harvard, Vancouver, ISO, etc.

Plus de sources

Chapitres de livres sur le sujet "Tumor Residual"

1

Cirillo, Luigi, Antonella Bacci, Raffaele Agati, and Marco Leonardi. "Early Residual Tumor." In Imaging Gliomas After Treatment. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2370-3_18.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

2

Caranci, Ferdinando, Francesco Briganti, and Arturo Brunetti. "Late Residual Tumor." In Imaging Gliomas After Treatment. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2370-3_19.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

3

Stecco, Alessandro, Francesco Fabbiano, Sara Zizzari, et al. "Low-grade Residual Tumor." In Imaging Gliomas After Treatment. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2370-3_20.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

4

Fabbiano, Francesco, Alessandro Stecco, Sara Zizzari, et al. "High-grade Residual Tumor." In Imaging Gliomas After Treatment. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2370-3_24.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

5

Stecco, Alessandro, Sara Zizzari, Francesco Fabbiano, et al. "High-grade Residual Tumor." In Imaging Gliomas After Treatment. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2370-3_25.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

6

Teicher, Beverly A. "Models for Minimal Residual Tumor." In Anticancer Drug Development Guide. Humana Press, 1997. http://dx.doi.org/10.1007/978-1-4615-8152-9_9.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

7

Stecco, Alessandro, Sara Zizzari, Francesco Fabbiano, et al. "Medium-low-grade Residual Tumor." In Imaging Gliomas After Treatment. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2370-3_21.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

8

Stecco, Alessandro, Sara Zizzari, Francesco Fabbiano, et al. "Medium-low-grade Residual Tumor." In Imaging Gliomas After Treatment. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2370-3_22.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

9

Stecco, Alessandro, Francesco Fabbiano, Sara Zizzari, et al. "Medium-low-grade Residual Tumor." In Imaging Gliomas After Treatment. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-2370-3_23.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

10

Pantel, K., and M. Otte. "Disseminated Tumor Cells: Diagnosis, Prognostic Relevance, and Phenotyping." In Minimal Residual Disease in Melanoma. Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-59537-0_2.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Actes de conférences sur le sujet "Tumor Residual"

1

Sharma, Khushi, Vivan Jaiswal, Tapan Kumar Dey, Shishir Singh Chauhan, Aditya Narayan Hati, and Mahesh Jangid. "Brain Tumor Detection and Classification Using Attention Based Residual Learning." In 2025 International Conference on Next Generation Communication & Information Processing (INCIP). IEEE, 2025. https://doi.org/10.1109/incip64058.2025.11019958.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

2

Liu, Zhipeng, Yidong Cao, Zeyuan Ju, Qiong Fu, Yi Ou, and Shangce Gao. "A Novel MRI Brain Tumor Detection Method Incorporated Residual Dendritic Learning." In 2024 Joint 13th International Conference on Soft Computing and Intelligent Systems and 25th International Symposium on Advanced Intelligent Systems (SCIS&ISIS). IEEE, 2024. https://doi.org/10.1109/scisisis61014.2024.10760086.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

3

Saeed, Abdullah, Namrata Dhanda, and Kapil Kumar Gupta. "Enhanced Brain Tumor Detection via ResNet50 Classification and Residual U-Net Segmentation." In 2025 2nd International Conference on Computational Intelligence, Communication Technology and Networking (CICTN). IEEE, 2025. https://doi.org/10.1109/cictn64563.2025.10932530.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

4

Prakash, Ankur, Mahima Jaiswal, Chakrapani Singh, and Vibhav Prakash Singh. "Semantic Segmentation of Brain Tumor Images Using Attention-based Residual U-Net Model." In 2024 International Conference on Control, Computing, Communication and Materials (ICCCCM). IEEE, 2024. https://doi.org/10.1109/iccccm61016.2024.11039928.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

5

Tiwari, Pradeep Kumar, and Prashant Johri. "Revolutionizing Brain Tumor Analysis: Unleashing the Potential of Residual UNet for Enhanced Segmentation Accuracy." In 2024 4th International Conference on Advance Computing and Innovative Technologies in Engineering (ICACITE). IEEE, 2024. http://dx.doi.org/10.1109/icacite60783.2024.10617138.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

6

Velmurugan, L., R. K. Maheswari, K. Janani, K. Agalya, M. Poornima, and K. C. Gayathri. "Enhanced Framework for MRI Brain Tumor Recognition with Residual Learning and Intuitive Heatmap Visualization." In 2024 International Conference on Innovative Computing, Intelligent Communication and Smart Electrical Systems (ICSES). IEEE, 2024. https://doi.org/10.1109/icses63760.2024.10910526.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

7

Elagamy, Mahmoud, Hossam Selim, and Saleh Mesbah Elkaffas. "Enhanced Brain Tumor Detection and Segmentation Using Identity Generative Adversarial Network and Attention Residual U-Net." In 2023 33rd International Conference on Computer Theory and Applications (ICCTA). IEEE, 2023. https://doi.org/10.1109/iccta60978.2023.10969194.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

8

Ullah, Muhammad Sami, Emaan Nazeeruddin, Muhammad Attique Khan, and Saddaf Rubab. "Brain Tumor Classification from MRI Scans using a Custom 4-Residual Deep Learning Architecture and Particle Swarm Optimization." In 2024 6th International Symposium on Advanced Electrical and Communication Technologies (ISAECT). IEEE, 2024. https://doi.org/10.1109/isaect64333.2024.10799805.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

9

Dharaneswar, Sholingapuram, and B. P. Santosh Kumar. "An In-Depth Method for Liver Tumor Segmentation and Classification using Trans-UNet and Vision Transformer-based Residual Attention Network." In 2024 5th International Conference on Electronics and Sustainable Communication Systems (ICESC). IEEE, 2024. http://dx.doi.org/10.1109/icesc60852.2024.10689998.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

10

Stylianopoulos, Triantafyllos, John D. Martin, Vikash P. Chauhan, Lance L. Munn, and Rakesh K. Jain. "Residual Stresses in Solid Tumors: Implications to Tumor Growth and Drug Delivery." In ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80235.

Texte intégral

Résumé :

The uncontrolled growth of cancer cells within a confined tissue space generates residual stresses in solid tumors [1,2]. These stresses contribute to tumor progression, pathological cellular behavior, and compression of lymphatic and blood vessels [3–5]. A major consequence of vascular compression is a decrease in pathways available for blood flow and delivery of diagnostic and therapeutic agents, resulting in insufficient and heterogeneous delivery of chemotherapy and nanomedicine. The reduced perfusion also causes hypoxia and acidity — two important barriers to treatment efficacy and promot

Styles APA, Harvard, Vancouver, ISO, etc.

Rapports d'organisations sur le sujet "Tumor Residual"

1

Kengsakul, Malika, Gatske Nieuwenhuyzen – de Boer, and Heleen van Beekhuizen. Radiological factors associated with residual disease after cytoreductive surgery for advanced ovarian cancer. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.1.0059.

Texte intégral

Résumé :

Review question / Objective: Which radiological factors associated with incomplete cytoreduction (gross residual disease) after cytoreductive surgery (CRS) for advanced ovarian cancer? Condition being studied: Findings of CT scan and discussion in the multidisciplinary tumor board meeting (MDO) are crucial to determine the therapeutic strategy for individual ovarian cancer patients. Preferably, patients undergo primary cytoreductive surgery (CRS) followed by adjuvant chemotherapy. However, when complete cytoreduction is not considered feasible, neoadjuvant chemotherapy followed by interval cyt

Styles APA, Harvard, Vancouver, ISO, etc.

2

Wu, Yingyue, Jia Luo, Jiani Ding, Lingxia Wang, and Bing Wei. Evidence mapping of histopathologic classification systems to characterize residual tumor in patients undergoing neoadjuvant treatment for breast cancer, including TNBC. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.8.0026.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!